{
    "code": "02024952",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024952",
    "time": "2016-09-16 03:39:11",
    "許可證字號": "衛署藥輸字第024952號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/12\/26",
    "發證日期": "97\/12\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "null",
    "中文品名": "舒倍生 8 毫克",
    "英文品名": "Suboxone 8mg",
    "適應症": "鴉片類物質成癮之替代療法。",
    "劑型": "118舌下錠",
    "包裝": "4~1000錠(CR AL-AL BLISTER)鋁箔盒裝 4~1000錠(PVC\/PVAC\/ACRYLATE LIDDING FOIL)鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "C第三級管制藥品",
    "主成分略述": "BUPRENORPHINE HYDROCHLORIDE, NALOXONE HCL DIHYDRATE",
    "限制項目": [
        "02輸入",
        "33第三級管制藥品",
        "55依本署89、12、12衛署藥字第0890035812號公告事項三經本署認定得免除銜接性試驗之新藥",
        "58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥"
    ],
    "申請商名稱": "1225201100  裕利股份有限公司",
    "申請商地址": "台北市松山區南京東路四段126號10樓，10樓之1-3",
    "主製造廠": {
        "製造廠名稱": "F130089000  RECKITT BENCKISER HEALTHCARE (UK) LIMITED",
        "製造廠廠址": "DANSOM LANE, HULL, EAST YORKSHIRE, HU8 7DS, UNITED KINGDOM",
        "製造廠公司地址": "103-105 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3UH, ENGLAND",
        "製造廠國別": "UNITED KINGDOM",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808801510",
            "成分名稱": "BUPRENORPHINE HYDROCHLORIDE",
            "含量描述": "",
            "含量": "8.6400000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2810000120",
            "成分名稱": "NALOXONE HCL DIHYDRATE",
            "含量描述": "",
            "含量": "2.4400000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "舒倍生8mg(第五階段 20160704)-105-07-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024952&Seq=002&Type=9"
        },
        {
            "title": "舒倍生-速百騰仿單中文-104-11-19.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024952&Seq=001&Type=9"
        },
        {
            "title": "Suboxone Tab_8mgCarton Artwork-105-07-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024952&Seq=005&Type=8"
        },
        {
            "title": "Suboxone Tab_8mgBlister Artwork-105-07-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024952&Seq=004&Type=8"
        },
        {
            "title": "Suboxone Tab_8mgCarton Artwork-104-09-09(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024952&Seq=007&Type=8"
        },
        {
            "title": "Suboxone Tab_8mgBlister Artwork-104-09-09(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024952&Seq=006&Type=8"
        },
        {
            "title": "TR828240 Suboxone 8mg Blister RB153216 TR817907-103-08-08.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024952&Seq=003&Type=8"
        },
        {
            "title": "Suboxone 8mg sublingual tablet_CR artwork_Taiwan-103-08-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024952&Seq=002&Type=8"
        },
        {
            "title": "Suboxone 8mg sublingual tablet_CR artwork_Taiwan-103-08-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024952&Seq=001&Type=8"
        }
    ]
}